Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 19, 2013
Event: Entry into a new Material Definitive Agreement (Credit Agreement) and termination of the existing credit facility.
Key Financial Metrics and Debt Structure
This filing details a refinancing transaction rather than operational financial results. Key debt metrics include:
- New Term Facility: $100 million senior secured term loan.
- New Revolving Facility: $100 million senior secured revolving credit facility (includes $20 million sublimit for letters of credit and $5 million for swingline loans).
- Initial Borrowings: $100 million under the Term Facility and approximately $41.4 million under the Revolving Facility.
- Use of Proceeds: Repayment of the Existing Credit Agreement (dated May 22, 2012) and general corporate purposes.
- Maturity: Five years.
- Interest Rates: Base rate (0.50% to 1.25%) or Eurodollar rate (1.50% to 2.25%) plus an applicable margin based on leverage ratios. Default rate increase of 2.0%.
- Commitment Fee: 0.20% to 0.35% per annum on the unused portion of the Revolver.
- Collateral: First priority security interests in substantially all assets of AngioDynamics and its material domestic subsidiaries.
Material Changes Versus Prior Period
The primary material change is the replacement of the Existing Credit Agreement with a new Credit Agreement on September 19, 2013.
- Termination: The Existing Credit Agreement was fully repaid and terminated.
- Repayment Schedule: The new Term Loan introduces a specific quarterly repayment schedule: 5% (Year 1), 5% (Year 2), 10% (Year 3), 15% (Year 4), and 65% (Year 5) of the principal amount.
- Covenants: The new agreement imposes two specific financial covenants not detailed in the prior agreement text provided:
- Fixed Charge Coverage Ratio: Must maintain a ratio of (Consolidated EBITDA minus Capital Expenditures) to (Cash Interest Expense plus Scheduled Principal Payments) of not less than 1.35 to 1.00.
- Leverage Ratio: Must maintain a ratio of Consolidated Total Indebtedness to Consolidated EBITDA of not greater than 3.75 to 1.00.
Guidance, Outlook, and Risks
Management Commentary: The filing does not contain forward-looking guidance regarding revenue or earnings. It focuses strictly on the terms of the new financing.
Risks and Contingencies:
- Covenant Compliance: Failure to maintain the 1.35:1.00 fixed charge coverage ratio or the 3.75:1.00 leverage ratio constitutes an event of default.
- Default Penalties: Interest rates may increase by 2.0% upon default.
- Security Interest: All obligations are secured by substantially all assets, limiting flexibility in asset disposition without lender consent.
Investor Verification Checklist
- Verify the company's current leverage ratio to ensure compliance with the new 3.75:1.00 maximum threshold.
- Review the company's EBITDA and capital expenditure projections to confirm ability to meet the 1.35:1.00 fixed charge coverage ratio.
- Confirm the exact utilization of the $41.4 million drawn from the Revolving Facility versus the $100 million Term Loan.
- Examine the full text of Exhibit 10.1 (Credit Agreement) for additional negative covenants or restrictions on dividends and additional indebtedness.